Medical Group

Annals of Antivirals and Antiretrovirals 


    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Type of LicenseCreative Commons
    • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
      • Permanent article identifierDOI (Digital Object Identifier)
    • Show +
    • NamePeertechz Publications Inc.,
      10880 Wilshire Blvd., Los Angeles, California, 90024, USA
    • Show +


    Peter Lloyd Nara

    Peter Lloyd Nara
    Private Compnay- Biological Mimetics, Inc., USA
    Tel: 301-514-4917; 301-51

    Skype: peter.nara-bmi

    More Info.

    Editorial Board Join as Editor

    Farsang Attila
    Project Manager
    Leading of Molecular Biological Laboratory

    Research Interest: Vaccine, Vaccinology, HIV, gp41, Animal Trials

    More Info.
    Pramod Kumar
    Department of Dermatology G.U.M
    Saham Hospital

    Research Interest: Paediatric Dermatology, Contact and Occupational Dermatoses, Clinical Dermatology, Experimental Dermatology and Dermatosurgery.

    More Info.
    Parmit Singh
    National Institute of Child Health and Human Development National Institutes of Health

    Research Interest: HIV-1, Retrovirology, Retroviruses, Splicing, Genetics and Molecular Biology, Chromatin Biology, NGS, Bioinformatics, Geneom Analysis.

    More Info.
    A P Malyshkin
    Division of Laboratory Diagnosis Orenburg Regional Tuberculosis Control Center

    Research Interest: Microbiology, Immunology, Infectious Diseases and Their Prevention.

    More Info.
    M Obulesu
    Department of Materials Science
    University of Tsukuba

    Research Interest: Alzheimer's Disease, Nanoparticles, Hydrogels, Biomaterials

    More Info.
    Larance Ronsard
    Harvard Medical School

    Research Interest: Identification of Immunomodulatory, Effects of a Drug in Rhesus Monkey Model, Canonical Signaling Pathways.

    More Info.
    Xiaofei Cheng
    Associated Professor
    Hangzhou Normal University
    PR China

    Research Interest: Plant Viruses; Virus-Host Interaction; Viral Infection; Anti-Viral Research

    More Info.
    Vykuntaraju K N Gowda
    Assistant Professor
    Pediatric Neurology Indira Gandhi Institute of Child Health

    Research Interest: Pediatric Epilepsy, Neuroinfections and Para Infectious Disorders, Developmental Neurology, Cerebral Palsy

    More Info.
    Marina K. Kukhanova
    Molecular Biology
    Institute of Russian Academy of Sciences

    Research Interest: Viral replication, antiviral and anticancer drug development, mechanism of action of potential antiviral compounds, cellular metabolism and toxicity, pharmacokinetics, enzymology, kinetics.

    More Info.
    Christophe Vanpouille
    Staff Scientist
    Intercellular Interactions NICHD, NIH

    Research Interest: HIV-1, Antivirals,Tissue; Ex Vivo, Pathogens.

    More Info.
    View more

    Castalagin: Some aspects of the mode of Anti-Herpes Virus Activity

    Published On: February 15, 2018 | Pages: 004 - 007

    Author(s): N Vilhelmova-Ilieva, D Deffieux, S Quideau, AS Galabov*
    Abstract View Full Article View DOI: 10.17352/aaa.000004

    Thiolutin Derivatives as inhibitor of RNA-Dependent RNA Polymerase (RdRP) of Hepatitis C Virus: An In-silico Approach

    Published On: January 17, 2018 | Pages: 001 - 003

    Author(s): Muhammad Imran Qadir*, Asma Munawar, Syed Bilal Hussain
    Abstract View Full Article View DOI: 10.17352/aaa.000003

    Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus

    Published On: October 10, 2017 | Pages: 005 - 007

    Author(s): Jawaria Khan*, Ardas Masood, Asma Noor, Anam Munir and Muhammad Imran Qadir
    Abstract View Full Article View DOI: 10.17352/aaa.000002

    Lack of Difference between the Reduced Dose and Full-Dose of Antiretroviral Therapy in Terms of the Decrease in Immune Activation

    Published On: January 28, 2017 | Pages: 001 - 004

    Author(s): Nicolè S*, Cucchetto G, Lanzafame M, Rigo F, Lattuada E, Concia E and Vento S
    Abstract View Full Article View DOI: 10.17352/aaa.000001

    Google Ads

    Peertechz @Social

    Peertechz Tweets

    Case Reports

    Pinterest on AAA